Involvement of the HERV-derived cell-fusion inhibitor, suppressyn, in the fusion defects characteristic of the trisomy 21 placenta

Jun Sugimoto(University of Missouri), Yoshiki Kudo(Hiroshima University)
Scientific Reports
June 22, 2022
Cited by 9


Related Papers